Offer - Urjas Oil for just ₹ 1 X
Lisotec 5 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of High BP. The alternative uses of Lisotec 5 Mg Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Lisotec 5 Mg Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Lisotec 5 Mg Tablet can also lead to other problems, which have been listed below. Such side effects of Lisotec 5 Mg Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Lisotec 5 Mg Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Lisotec 5 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Lisotec 5 Mg Tablet is contraindicated in people with pre-existing medical conditions like Angioedema, Heart Failure as it can result in adverse effects. Other contraindications of Lisotec 5 Mg Tablet have been discussed in the sections ahead.
Additionally, Lisotec 5 Mg Tablet may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Lisotec 5 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Lisotec 5 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Lisotec 5 Mg Tablet safe for pregnant women?
Lisotec should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Lisotec 5 Mg Tablet safe during breastfeeding?
Lisotec should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Lisotec 5 Mg Tablet on the Kidneys?
Lisotec rarely affects the kidneys.
What is the effect of Lisotec 5 Mg Tablet on the Liver?
Lisotec is rarely harmful for the liver.
What is the effect of Lisotec 5 Mg Tablet on the Heart?
Lisotec is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Lisotec 5 Mg Tablet unless your doctor advises you to do so -
Is this Lisotec 5 Mg Tablet habit forming or addictive?
Forming a habit of Lisotec 5 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Lisotec 5 Mg Tablet. So it is best to avoid driving.
Is it safe?
Lisotec 5 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Lisotec 5 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Lisotec 5 Mg Tablet
Taking Lisotec 5 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Lisotec 5 Mg Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Lisotec 5 Mg Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zestril (lisinopril)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169